Wojcik, Kaitlyn M.
Kamil, Dalya
Zhang, Julia
Wilson, Oliver W. A.
Smith, Laney
Butera, Gisela
Isaacs, Claudine
Kurian, Allison
Jayasekera, Jinani
Funding for this research was provided by:
Division of Intramural Research, National Institute on Minority Health and Health Disparities
Article History
Received: 29 August 2023
Accepted: 12 March 2024
First Online: 28 March 2024
Declarations
:
: This review used study-level data, so no ethical approval is required.
: Claudine Isaacs has received research funding to her institution from Novartis, Pfizer, Genentech, and GSK, and she has served in a consulting or advisory role for Genentech, PUMA, Seattle Genetics, AstraZeneca, Novartis, Pfizer, ION, and Gilead. She receives royalties from Kluwer and McGraw Hill. Allison Kurian has received research funding to her institution from Myriad Genetics. All other authors declare no financial or non-financial competing interests.
: The contents and views in this manuscript are those of the authors and should not be construed to represent the views of the National Institutes of Health.Opinions and comments expressed in this paper belong to the authors and do not necessarily reflect those of the US Government, Department of Health and Human Services, National Institutes of Health, or the National Institute on Minority Health and Health Disparities. The study funders had no role in the design of the study, the collection, analysis, or interpretation of the data, the writing of the manuscript, or the decision to submit the manuscript for publication.